(Q36014812)

English

Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Martino Introna

9

object named as

Martino Introna

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Giovanna D'Amico

object named as

Giovanna D'Amico

14

0 references

Adriana Balduzzi

object named as

Adriana Balduzzi

5

0 references

author name string

Giovanna Lucchini

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Erica Dander

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Fabio Pavan

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Irene Di Ceglie

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Paolo Perseghin

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Giuseppe Gaipa

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Alessandra Algarotti

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Alessandro Rambaldi

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Attilio Rovelli

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Andrea Biondi

12

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Ettore Biagi

13

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

30 May 2012

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Stem Cells International

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

2012

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

690236

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Molecular monitoring of viral infections after hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Mesenchymal stromal cells: current understanding and clinical status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Potential of mesenchymal stem cell therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Immunomodulatory properties of mesenchymal stromal cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Interactions between human mesenchymal stem cells and natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369546

2 October 2017

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F690236

21 January 2018

The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F690236

21 January 2018

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F690236

21 January 2018

Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts.

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F690236

21 January 2018

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

1 reference

https://pubmed.ncbi.nlm.nih.gov/22701127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase

1 reference

https://pubmed.ncbi.nlm.nih.gov/22701127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22701127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/22701127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22701127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/22701127

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2012/690236

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36014812&oldid=1801009812"